On Wednesday, 1971 stocks advanced, 2248 declined and 172 remained unchanged on Bombay Stock Exchange with advance decline ratio of 0.87 indicating a negative closing. The trend of the major indices on Wednesday’s trading is given in the table below.
On NSE, 79 securities advanced and closed at a new 52-week high whereas 43 securities sank to close at their new 52-week lows. Nifty Auto, Nifty PSU Bank and Nifty Pharma were among the biggest gainers. Nifty IT and Nifty Energy were among the biggest losers.
Bansal Wire Industries (-0.04%) announced that its wholly owned subsidiary, BWI Steel Private Limited, has signed a Memorandum of Understanding with the Ministry of Steel under the Government of India’s Production Linked Incentive (PLI) Scheme 1.2 for Specialty Steel. Under the MoU, BWI Steel will undertake capacity expansion for manufacturing stainless steel wire, committing to set up a production capacity of 70,000 tonnes per annum.
Coforge (-1.97%) announced expanded capabilities for its agentic AI‑powered code intelligence and modernization platform, Coforge CodeInsightAI, which sits at the core of its Forge‑X ecosystem. CodeInsightAI is positioned as an AI‑first modernization platform, automating both reverse and forward engineering at enterprise scale. The enhanced capabilities target persistent challenges: legacy system complexity, mounting technical debt, fragmented technology landscapes, and shrinking legacy talent pools.
Bharti Airtel (+0.04%) rolled out an advanced AI powered Fraud Alert system designed to protect customers against the growing risk of OTP related banking frauds. The system delivers real‑time protection by detecting risky scenarios during live calls and alerting users before they share sensitive banking credentials. Fraudsters often exploit urgency around OTPs for services like deliveries, logins, or bill payments, impersonating officials to trick customers. Airtel’s AI engine identifies when a bank OTP is generated during a suspicious incoming call and immediately triggers a fraud risk alert.
OneSource Speciality Pharma (-0.13%) announced that it has received approval from the Saudi Food and Drug Authority (SFDA) for its generic version of Ozempic® (semaglutide) in Saudi Arabia. The approval enables commercialisation in the Kingdom through an exclusive partnership with Hikma Pharmaceuticals PLC, covering the Middle East and North Africa region. It will manufacture and supply semaglutide from its Bengaluru facility, while Hikma will manage distribution across private and institutional channels using its established regional network.
SJVN (+6.29%) reported Q3 FY26 performance with revenue from operations surging 61.25% y o y to ₹1,081.97 crore compared with ₹670.99 crore in Q3 FY25. Net profit for the quarter stood at ₹224.31 crore, marking a 50.8% y o y increase from ₹148.75 crore in the corresponding period last year.
Sandhar Technologies (-6.43%) reported Q3 FY26 performance with revenue from operations rising 21.7% y o y to ₹1,184.64 crore compared with ₹973.69 crore in Q3 FY25. Net profit after tax stood at ₹33.45 crore, marking an 11.7% increase from ₹29.95 crore in the corresponding quarter last year.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below:
Trade Relief: Yes, for Now. But Turning Point? Maybe
Debashis Basu,
13 February 2026
The cloud hanging over the Indian stock market has lifted, for now. India’s trade deals with the US and the European Union (EU) have reduced one of the biggest risks embedded in Indian equities over the past year. Amid tariff and...
Emcure Pharma Posts Strong Q3 as Margins Expand; Semaglutide Launch Marks Strategic Shift
Moneylife Digital Team
11 February 2026
Emcure Pharmaceuticals Limited (Emcure) was incorporated in 1981 by Satish Mehta, a first-generation entrepreneur, with the aim of providing affordable and high-quality healthcare to patients. Emcure is transitioning from a...
Acutaas Chemicals: CDMO-led Profit Surge
Moneylife Digital Team
11 February 2026
Acutaas Chemicals Limited makes advanced pharmaceutical intermediates (APIs) and specialty chemicals. Under its API segment, it manufactures molecules that are under clinical trial or which have been launched in the patented and...
Defence Push Drives BEL Order-book to Record ₹73,450 Crore
Moneylife Digital Team
11 February 2026
The ministry of defence (MoD) has been allocated a record ₹7.85 lakh crore for FY26-27, marking a 15.19% increase over the Budgetary Estimates of FY25-26. Capital expenditure (capex) has risen to an all-time high of ₹2.19 lakh crore,...
